NFG
RETA

Next Financial Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Next Financial Group’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12
Closed -$1K – 2563
2019
Q3 		$1K Buy
+12
New +$1.02K ﹤0.01% 2276

Other funds holding RETA

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Next Financial Group's RETA Position: Q4 2019 in Review

Next Financial Group sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2019, closing a stake of 12 shares — an estimated $1K sold.

Next Financial Group first reported a position in RETA in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 218 funds tracked by Wall St. Rank hold RETA as of Q4 2019.

  • Next Financial Group reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2019 after selling out during the quarter.
  • Next Financial Group sold 12 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2019, an estimated $1K.
  • Next Financial Group first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2019 and held it in 1 quarter.
  • Next Financial Group's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1K in Q3 2019.
  • 218 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2019.

Based on Next Financial Group's 13F filing for Q4 2019, filed 21 Jan 2020.